Welcome to our dedicated page for Warpaint London news (Ticker: WPNTF), a resource for investors and traders seeking the latest updates and insights on Warpaint London stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Warpaint London's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Warpaint London's position in the market.
Warpaint London PLC announced record interim results for the six months ended 30 June 2024.
Revenue increased by 25% to £45.8 million from £36.7 million in H1 2023. UK revenue rose 17% to £15.5 million, while international revenue grew 30% to £30.3 million. The W7 brand saw a 25% increase in sales, and Technic sales grew by 34%.
Gross profit margin improved by 334 basis points to 42.5%. EBITDA increased 66% to £12.0 million, and profit from operations was up 75% to £11.0 million. Basic EPS rose 67% to 10.37p.
The company declared an increased interim dividend of 3.5p per share, up 17%. Cash as of 30 June 2024 was £5.5 million, reflecting increased stock and tax payments.
Warpaint highlighted strong sales growth in the UK and Europe, ongoing expansion plans, and expects the second half to be weighted due to seasonal sales.
Warpaint London plc (AIM:W7L)(OTCQX:WPNTF), a specialist supplier of colour cosmetics and owner of the W7 and Technic brands, has announced it will release its interim results for the six months ended 30 June 2024 on Tuesday 17 September 2024. The company will host an analyst briefing at 9:30 a.m. BST on the day of the results announcement.
Warpaint London sells branded cosmetics under various names, with W7 and Technic being the lead brands. W7 is primarily sold to major retailers in the UK and to international distributors, while Technic focuses on the gifting market in the UK and continental Europe. The company also supplies cosmetics under other brand names including Man'stuff, Body Collection, and Chit Chat, each targeting different demographics.
Warpaint London PLC (AIM: W7L, OTCQX: WPNTF), a specialist supplier of color cosmetics and owner of W7 and Technic brands, announced that all resolutions were passed at the Annual General Meeting (AGM) held on June 26, 2024. Key resolutions included the approval of the 2023 Annual Report, director's remuneration report, re-election of board members, re-appointment of BDO as auditors, and the declaration of a final dividend of 6.0 pence per share. The resolutions received overwhelming support from shareholders, with the approval rates ranging from 92.67% to 100%.
Warpaint London PLC (AIM:W7L, OTCQX:WPNTF) announced positive trading updates at their Annual General Meeting on June 26, 2024. The company expects sales for the first half of 2024 to be approximately £46 million, up from £36.7 million in the same period in 2023. Margins are also reported to be ahead of the previous year. Warpaint is expanding its presence in larger global retailers and plans to roll out new products in the second half of the year. The final dividend of 6.0 pence per share is pending shareholder approval, payable on July 5, 2024.
Warpaint London will present at the Small-Cap Growth Virtual Investor Conference on 13 June 2024.
Sam Bazini, CEO and co-founder, will lead the presentation at 10:00 AM ET. Investors can interact live and ask questions, with an archived webcast available post-event.
Q1 2024 highlights include:
- Unaudited Group sales of £23.5 million, a 28% increase from Q1 2023.
- Strong gross margin and a healthy balance sheet with £7.5 million in cash.
- Notable US expansions include CVS, Walmart, and Five Below, with significant orders and store rollouts.
- UK expansions feature launches in Morrisons, Boots, and Superdrug, with further plans for Tesco and others.